• Overview
  • News
  • Analysis
  • Recos
  • Financials
  • Technicals
  • Peers
  • Shareholdings
  • MF
  • Corp Actions
  • About

Insights

  • Company has spent 2.71% of its operating revenues towards interest expenses and 14.62% towards employee cost in the year ending Mar 31, 2020. (Source: Standalone Financials)

InsightsSakar Healthcare Ltd.

  • Employee & Interest Expense

    Company has spent 2.71% of its operating revenues towards interest expenses and 14.62% towards employee cost in the year ending Mar 31, 2020. (Source: Standalone Financials)

Do you find these insights useful?

  • hate it

  • meh

  • love it

Key Metrics

  • 26.14
  • 6.24
  • 279.28
  • 17
  • 3.44
  • 0.00
  • 10.00
  • 0.12
  • 163.12

Returns

  • 1 Day-0.03%
  • 1 Week-4.09%
  • 1 Month-9.46%
  • 3 Months17.0%
  • 1 Year128.5%
  • 3 YearsN.A.
  • 5 YearsN.A.

Sakar Healthcare Stock Analysis

EARNINGS
FUNDAMENTAL
RELATIVE VALUATION
RISK
PRICE MOMENTUM

NO RATING (NR)

NEGATIVE (1-3)

NEUTRAL (4-7)

POSITIVE (8-10)

In-depth Reports on 4000+ Indian Stocks worth ₹1,499 with ET Prime membership

START FREE TRIAL

Recommendations

Financials

  • Income (P&L)

  • Balance Sheet

  • Cash Flow

  • Ratios

  • Insights

    • Employee & Interest Expense

      Company has spent 2.71% of its operating revenues towards interest expenses and 14.62% towards employee cost in the year ending Mar 31, 2020. (Source: Standalone Financials)
    QuarterlyMar 2021Dec 2020Sep 2020
    Total Income22.1027.0626.38
    Total Income Growth (%)-18.352.5829.43
    Total Expenses19.4324.0120.24
    Total Expenses Growth (%)-19.0618.6522.53
    EBIT2.663.056.14
    EBIT Growth (%)-12.69-50.3858.94
    Profit after Tax (PAT)1.731.804.56
    PAT Growth (%)-3.62-60.5576.38
    EBIT Margin (%)12.0411.2623.28
    Net Profit Margin (%)7.856.6517.29
    Basic EPS (₹)1.171.203.04
    Quarterly | AnnualMar 2021Dec 2020Sep 2020Jun 2020Mar 2020
    Total Income22.1027.0626.3820.3819.29
    Total Income Growth (%)-18.352.5829.435.66-14.21
    Total Expenses19.4324.0120.2416.5215.57
    Total Expenses Growth (%)-19.1018.6422.556.09-17.95
    EBIT2.673.056.143.873.72
    EBIT Growth (%)-12.38-50.3758.843.886.01
    Profit after Tax (PAT)1.741.804.562.592.86
    PAT Growth (%)-3.09-60.5476.22-9.5729.51
    EBIT Margin (%)12.0911.2623.2818.9719.29
    Net Profit Margin (%)7.896.6517.2912.7014.84
    Basic EPS (₹)1.171.203.041.721.88
    Quarterly | Annual FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    Total Revenue85.0068.9353.6144.9041.43
    Total Revenue Growth (%)23.3128.5819.388.3818.20
    Total Expenses72.7759.7047.4840.0838.55
    Total Expenses Growth (%)21.9025.7218.473.9618.13
    Profit after Tax (PAT)9.626.693.813.382.33
    PAT Growth (%)43.7875.4512.9245.1026.78
    Operating Profit Margin (%)17.4416.8516.4116.9914.10
    Net Profit Margin (%)11.599.807.187.645.64
    Basic EPS (₹)6.434.933.123.082.91

    All figures in Rs Cr, unless mentioned otherwise

    No reported Profit & Loss Statement are available.

  • Annual FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    Total Assets115.1297.3881.1070.5951.11
    Total Assets Growth (%)18.2220.0714.8938.111.85
    Total Liabilities33.8025.6529.6135.0833.95
    Total Liabilities Growth (%)31.77-13.37-15.593.33-3.96
    Total Equity81.3271.7351.4935.5017.16
    Total Equity Growth (%)13.3739.3145.04106.8815.71
    Current Ratio (x)1.521.442.141.671.11
    Total Debt to Equity (x)0.180.110.220.601.13
    Contingent Liabilities-----

    All figures in Rs Cr, unless mentioned otherwise

    No reported Balance Sheet are available.

  • Insights

    • Decrease in Cash from Investing

      Company has used Rs 13.68 cr for investing activities which is an YoY decrease of 45.09%. (Source: Standalone Financials)
    Annual FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    Net Cash flow from Operating Activities10.1216.145.269.199.19
    Net Cash used in Investing Activities-13.68-24.91-8.28-3.59-3.59
    Net Cash flow from Financing Activities3.488.77-12.99-6.30-6.30
    Net Cash Flow-0.070.00-16.01-0.70-0.70
    Closing Cash & Cash Equivalent0.300.37-15.550.230.23
    Closing Cash & Cash Equivalent Growth (%)-19.32-102.36-6,883.120.00-75.43
    Total Debt/ CFO (x)1.460.492.132.312.10

    All figures in Rs Cr, unless mentioned otherwise

    No reported Cash Flow Statement are available.

  • Annual FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    Return on Equity (%)11.839.327.409.5113.57
    Return on Capital Employed (%)14.3513.7712.7512.9714.94
    Return on Assets (%)8.356.874.704.784.55
    Interest Coverage Ratio (x)6.435.083.372.801.98
    Asset Turnover Ratio (x)72.0770.0865.4462.5780.66
    Price to Earnings (x)7.7711.0519.0818.52-
    Price to Book (x)0.921.031.411.76-
    EV/EBITDA (x)4.144.656.367.64-
    EBITDA Margin (%)25.9825.6924.7124.6720.73

    No reported Financial Ratios are available.

Financial InsightsSakar Healthcare Ltd.

  • Income (P&L)
  • Cash Flow
    • Employee & Interest Expense

      Company has spent 2.71% of its operating revenues towards interest expenses and 14.62% towards employee cost in the year ending Mar 31, 2020. (Source: Standalone Financials)

    • Decrease in Cash from Investing

      Company has used Rs 13.68 cr for investing activities which is an YoY decrease of 45.09%. (Source: Standalone Financials)

Do you find these insights useful?

  • hate it

  • meh

  • love it

Technicals

  • Buy / Sell Signals

  • Price Analysis

  • Pivot Levels & ATR

  • Chart

  • Stock doesnt have any Buy/Sell Signals.

  • Price Analysis Data details are not available.

  • Pivot Levels

    R1R2R3PIVOTS1S2S3
    Classic-------

    Average True Range

    5 DAYS14 DAYS28 DAYS
    ATR---

Peer Comparison

  • Stock Performance

  • Ratio Performance

    • CHART
    • TABLE
    • 1D
    • 1W
    • 1M
    • 3M
    • 6M
    • 1Y
    • 5Y
  • Ratio Performance

    NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
    Sakar Healthcare26.143.4311.8314.358.3523.4417.4411.596.431.520.181.46
    Max Healthcare113.4629.142.236.611.114.2310.282.450.520.880.656.32
    Fortis Healthcare64.533.20-1.791.61-0.98-4.593.98-2.57-1.450.840.192.36
    Aster DM Health41.102.954.385.861.268.485.752.022.971.140.571.22
    Narayana Hruday58.619.49-1.271.29-0.514.271.03-0.28-0.700.950.471.70
    Add More

    Annual Ratios (%)

    Choose from Peers

    • Krishna Institute of Medical Sciences Ltd.
    • Healthcare Global
    • Shalby
    • Kovai Medical
    • Indraprastha Med

    See All Parameters

Peers InsightsSakar Healthcare Ltd.

Do you find these insights useful?

  • hate it

  • meh

  • love it

Shareholding Pattern

  • QOQ Change

  • Total Shareholdings

  • Showing Shareholding as on 30 Jun 2021

    Category30 Jun 202131 Mar 202131 Dec 202030 Sep 2020
    Promoters67.5474.0272.8872.88
    Pledge0.000.000.000.00
    FII8.760.000.000.00
    DII0.000.000.000.00
    Mutual Funds0.000.000.000.00
    Others23.7025.9827.1227.12
  • Showing Shareholding as on 30 Jun 2021

    CategoryNo. of SharesPercentage% Change QoQ
    Promoters1,15,61,04367.54 %-6.48
    Pledge00.00 %0.00
    FII15,00,0008.76 %-
    Others40,56,95723.70 %-2.28

MF Ownership

MF Ownership details are not available.

Top Searches:

Corporate Actions

  • Board Meeting/AGM

  • Dividends

  • Others
  • Meeting DateAnnounced onPurposeDetails
    May 31, 2021May 25, 2021Board MeetingAudited Results
    Feb 05, 2021Jan 27, 2021Board MeetingQuarterly Results
    Jan 21, 2021Jan 18, 2021Board MeetingOthers
    Oct 29, 2020Oct 23, 2020Board MeetingQuarterly Results
    Jun 25, 2020Jun 18, 2020Board MeetingAudited Results
  • Dividend announcements are not available.

  • No other corporate actions details are available.

About Sakar Healthcare

Sakar Healthcare Ltd., incorporated in the year 2004, is a Small Cap company (having a market cap of Rs 279.28 Crore) operating in Hospitals & Allied Services sector. Sakar Healthcare Ltd. key Products/Revenue Segments include Pharmaceutical Products for the year ending 31-Mar-2020. Show More

  • Executives

  • Auditors

  • SS

    Sanjay S Shah

    Chairman & Managing Director

    AS

    Aarsh S Shah

    Joint Managing Director

    RS

    Rita S Shah

    Whole Time Director

    HP

    Hardik P Mehta

    Independent Director

    Show More

Address

Block No. 10/13,Village: Changodar,Sarkhej- Bavla Highway,Ahmedabad District, Gujarat - 382213

More Details

Sakar Healthcare Share Price Update

Sakar Healthcare Ltd. share price moved down by -0.03% from its previous close of Rs 163.20. Sakar Healthcare Ltd. stock last traded price is 163.15

Share PriceValue
Today/Current/Last163.15
Previous Day163.20

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

Contact us

Find us at the office

Trailor- Verkamp street no. 63, 81415 Zagreb, Croatia

Give us a ring

Dezha Manci
+38 695 645 231
Mon - Fri, 8:00-22:00

Reach out